GO
Loading...

Johnson & Johnson

More

  • Early Glance: Pharmaceuticals companies Monday, 18 Aug 2014 | 10:29 AM ET

    Baxter International Inc. rose$. 81 or 1.1 percent, to $75.22. Bristol-Myers Squibb Co. rose$. 13 or. 3 percent, to $49.81. Hospira rose$. 76 or 1.4 percent, to $55.78.

  • Early Glance: Medical Devices companies Monday, 18 Aug 2014 | 10:29 AM ET

    Allergan fell $1.26 or. 8 percent, to $157.00. Baxter International Inc. rose$. 81 or 1.1 percent, to $75.22. Boston Scientific Corp. rose$. 14 or 1.1 percent, to $12.60.

  • Final Glance: Medical Devices companies Friday, 15 Aug 2014 | 6:16 PM ET

    Allergan rose $2.66 or 1.7 percent, to $158.26. Baxter International Inc. fell$. 34 or. 5 percent, to $74.41. Boston Scientific Corp. fell$. 12 or 1.0 percent, to $12.46.

  • Final Glance: Pharmaceuticals companies Friday, 15 Aug 2014 | 6:16 PM ET

    Baxter International Inc. fell$. 34 or. 5 percent, to $74.41. Bristol-Myers Squibb Co. fell$. 14 or. 3 percent, to $49.68. Hospira fell$. 69 or 1.2 percent, to $55.02.

  • Midday Glance: Pharmaceuticals companies Friday, 15 Aug 2014 | 1:15 PM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $74.21. Bristol-Myers Squibb Co. fell$. 33 or. 7 percent, to $49.49. Hospira fell$. 90 or 1.6 percent, to $54.81.

  • Midday Glance: Medical Devices companies Friday, 15 Aug 2014 | 1:15 PM ET

    Allergan rose $2.17 or 1.4 percent, to $157.77. Baxter International Inc. fell$. 54 or. 7 percent, to $74.21. Boston Scientific Corp. fell$. 15 or 1.2 percent, to $12.43.

  • Early Glance: Medical Devices companies Friday, 15 Aug 2014 | 11:21 AM ET

    Allergan rose $3.59 or 2.3 percent, to $159.19. Baxter International Inc. rose$. 38 or. 5 percent, to $75.13. Johnson& Johnson rose$. 07 or. 1 percent, to $102.09.

  • Scientists racing to test Ebola vaccines in humans Thursday, 14 Aug 2014 | 5:36 PM ET

    New details about the development of the vaccines emerged this week as the World Health Organization declared it OK to use experimental drugs and vaccines as authorities try to contain the outbreak that has killed more than 1,000 people.

  • Early Glance: Pharmaceuticals companies Thursday, 14 Aug 2014 | 10:33 AM ET

    Baxter International Inc. fell$. 23 or. 3 percent, to $74.73. Bristol-Myers Squibb Co. rose$. 60 or 1.2 percent, to $49.77. Hospira fell$. 07 or. 1 percent, to $55.09.

  • Final Glance: Pharmaceuticals companies Wednesday, 13 Aug 2014 | 6:14 PM ET

    Baxter International Inc. rose$. 69 or. 9 percent, to $74.96. Bristol-Myers Squibb Co. rose$. 19 or. 4 percent, to $49.17. Hospira rose$. 62 or 1.1 percent, to $55.16.

  • Final Glance: Medical Devices companies Wednesday, 13 Aug 2014 | 6:14 PM ET

    Allergan rose $1.86 or 1.2 percent, to $154.90. Baxter International Inc. rose$. 69 or. 9 percent, to $74.96. Boston Scientific Corp. rose$. 11 or. 9 percent, to $12.48.

  • Vertex to end sales of hepatitis C drug Incivek Wednesday, 13 Aug 2014 | 2:42 PM ET

    Aug 13- Vertex Pharmaceuticals Inc is stopping U.S. sales and distribution of its Incivek hepatitis C treatment, whose use has been largely supplanted by the new Sovaldi drug from Gilead Sciences Inc.. Incivek was approved in 2011 and quickly rose to annual sales of more than $1 billion.

  • Midday Glance: Pharmaceuticals companies Wednesday, 13 Aug 2014 | 1:50 PM ET

    Baxter International Inc. rose$. 61 or. 8 percent, to $74.88. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $49.37. Hospira rose$. 48 or. 9 percent, to $55.02.

  • Midday Glance: Medical Devices companies Wednesday, 13 Aug 2014 | 1:50 PM ET

    Allergan rose $2.11 or 1.4 percent, to $155.15. Baxter International Inc. rose$. 61 or. 8 percent, to $74.88. Boston Scientific Corp. rose$. 11 or. 9 percent, to $12.48.

  • Aug 13- BioCryst Pharmaceuticals Inc said the U.S. government exercised options to test the company's antiviral drug in humans and non-primates as a treatment for hemorrhagic fever viruses such as Ebola.

  • Early Glance: Medical Devices companies Wednesday, 13 Aug 2014 | 10:32 AM ET

    Allergan rose $1.27 or. 8 percent, to $154.31. Baxter International Inc. rose$. 49 or. 7 percent, to $74.76. Boston Scientific Corp. rose$. 01 or. 1 percent, to $12.39.

  • *Liberia to treat infected doctors with trial drug ZMapp. LONDON/ GENEVA, Aug 12- People infected in the West African Ebola outbreak can be offered untested drugs, the World Health Organisation said on Tuesday, but the scarcity of supplies has raised questions about who gets priority access to treatment.

  • *Liberia to treat infected doctors with trial drug ZMapp. LONDON/ GENEVA, Aug 12- People infected in the West African Ebola outbreak can be offered untested drugs, the World Health Organisation said on Tuesday, but the scarcity of supplies raises questions about who gets priority access to treatment.

  • Early Glance: Pharmaceuticals companies Tuesday, 12 Aug 2014 | 12:14 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $74.04. Bristol-Myers Squibb Co. fell$. 01 or percent, to $49.09. Pfizer fell$. 01 or percent, to $28.24.

  • Final Glance: Medical Devices companies Monday, 11 Aug 2014 | 6:02 PM ET

    Allergan fell $3.44 or 2.2 percent, to $153.39. Baxter International Inc. rose$. 30 or. 4 percent, to $74.20. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.26.